# NMT Capital

NMT Capital is a Private Equity based in Norwell, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Norwell, United States
- **Region:** North America
- **Address:** Norwell, MA, United States
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** nmtcapital.com
- **LinkedIn:** https://www.linkedin.com/company/nmt-capital

## Regulatory record

- **Reports private funds:** No

## About

NMT Capital ("Nexus") is a globally oriented private equity firm currently managing investment funds based in Europe and in the US. Its portfolio companies are located in both North America and Europe and span early to late stage of development. Nexus also acts as a consultant to various global investment banks on sourcing and evaluating private medical companies. It is managed by Principals with deep experience in medical technology, life science, advanced materials, software, communications and information technology.

## Sectors

- Medical Technology
- Life Sciences
- Advanced Materials
- Enterprise Software
- Communications
- Information Technology

## Offices

- Quincy, MA
- San Francisco, CA
- London, UK
- Munich, Germany
- Geneva, Switzerland
- Tokyo, Japan

## People

- Gregory F. Zaic — Principal
- Thomas E. Hancock — Principal
- Edwin Snape — PhD, Senior Advisor
- John F. Rousseau — Jr., Senior Advisor

## Questions

### How does NMT Capital source its investment opportunities?

NMT Capital operates a dual sourcing engine. As a principal investor it evaluates deals for its own funds; simultaneously it acts as a paid consultant to global investment banks seeking to source and evaluate private medical companies. This advisory work gives NMT early visibility into companies considering a sale or capital raise, creating a proprietary pipeline not available to firms relying solely on standard GP networks.

### What stages does NMT Capital target?

NMT Capital invests across the full spectrum, from seed and early-stage venture capital through growth and late-stage expansion to buyouts. This multi-stage approach allows the firm to back companies at inception via its venture allocation and supply follow-on capital via its growth and buyout vehicles as those companies mature.

### How are NMT Capital's advisory and investment activities separated?

The firm describes its advisory services as a distinct consulting line assisting investment banks in sourcing and evaluating private medical companies, but it does not publicly detail how it prevents information asymmetry between its advisory clients and its own fund portfolios. The same principals averaging more than 20 years of experience oversee both activities.

### Does NMT Capital have any disclosed fund sizes or AUM?

NMT Capital does not publicly disclose assets under management, cumulative deployment, or fund sizes. Its web presence is limited to a single-page description of strategy and geography, and no public SEC filing or press release has been identified that reports a fund size or AUM figure.

## Related profiles

- [NLV](https://altss.com/profile/nlv)
- [NMV](https://altss.com/profile/nmv)

---

Last updated: 2026-08-11T15:07:34.613Z

Canonical page: https://altss.com/profile/nmt-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology